Equity
€4.2m from €12.4m in 2016
Equity fell by 66% in 9 years.
LABOFLORA EN/OF MARC PONNET EN/OF LIEVEKE REYNAERT
Lifetime
20 annual accounts with figures on one time axis, 33 filings since 1993peak €446,038 (2010)
€251,246▲ 3.8%
peak €544,445 (2013)
€85,492▲ 5.8%
peak €12.4m (2016)
€4.2m▲ 2.1%
€99,856▼ 60.1%
Board5 names since 2017
3 directorsLaboflora NV and 2 others
Owners
consolidatesMonbeau
Documentsfilings and deeds
08-10-202669 days late
2025financial year
Debts from €250,227 to €99,856
Key points
from the 2025 annual accountsChecked score
94
Excellent
Financially stronger than 69% of small companies without a NACE code
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.1%
01-2025: 0.1%● unchanged vs 12-2024
02-2025: 0.1%● unchanged vs 01-2025
03-2025: 0.1%● unchanged vs 02-2025
04-2025: 0.1%● unchanged vs 03-2025
05-2025: 0.1%● unchanged vs 04-2025
06-2025: 0.1%● unchanged vs 05-2025
07-2025: 0.2%▲ +0.1 percentage points vs 06-2025
08-2025: 0.3%▲ +0.1 percentage points vs 07-2025
09-2025: 0.1%▼ -0.2 percentage points vs 08-2025
10-2025: 0.1%● unchanged vs 09-2025
11-2025: 0.1%● unchanged vs 10-2025
12-2025: 0.1%● unchanged vs 11-2025
01-2026: 0.1%● unchanged vs 12-2025
02-2026: 0.1%● unchanged vs 01-2026lowest value
03-2026: 0.1%● unchanged vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026
05-2026: 0.1%● unchanged vs 04-2026
06-2026: 0.1%● unchanged vs 05-2026
07-2026: 0.1%● unchanged vs 06-2026
08-2026: 0.3%▲ +0.2 percentage points vs 07-2026
09-2026: 0.4%▲ +0.1 percentage points vs 08-2026highest value
10-2026: 0.1%▼ -0.3 percentage points vs 09-2026
11-2026: 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
raises risk
Last filed accounts filed 69 days late; 1 of the last 3 accounts late
Liquidity: current ratio 35.19, cash €31,874
lowers risk
Size: total assets €4.3m
Equity €4.2m (97.7% of total assets)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, small). It does better than 82% of them on solvency, 58% on liquidity, 77% on profitability and 58% on growth.
The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 14,766 companies had the same profile as LABOFLORA EN/OF MARC PONNET EN/OF LIEVEKE REYNAERT has now. Each dot stands for 37 companies, two years later.
96.2%
were still trading
3.5%
stopped another way
0.2%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of LABOFLORA EN/OF MARC PONNET EN/OF LIEVEKE REYNAERT itself: 0.1% within 12 months.
Test of the method
The method was tested on the 497,448 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 14,766 companies, not a prediction for LABOFLORA EN/OF MARC PONNET EN/OF LIEVEKE REYNAERT. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €390,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 35.19 (15.05 in 2024), above the usual 1.5. Short-term debt is 2.3% and cash 0.7% of total assets. 2.3% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises risk
raises risk · 2025 accounts filed 69 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 08-10-2026, 69 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filingsDeviation from the deadline
2025
69 days late
2024
29 days late
2023
6 days late
2022
31 days late
2021
3 days early
2020
30 days late
2019
39 days late
← before the deadline
after the deadline →
tick = median of all Belgian filings
The company filed its last 7 accounts on average 29 days after the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 August (4 of the last 5 accounts filed within 32 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
11-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
- Monbeau 90%score 81equity €2.2m (2025) · 2025 annual accounts of Monbeau
- Monbeau NV consolidatesannual accounts 2025
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0448541064
Amendment of the articles
General meeting of 14-12-2023 · Gazette deed
2 directors resigning, 2 reappointments
Resignations: Cicerone and Belsac · Permanent representatives: Marc Ponnet and Lieveke Reynaert · Reappointments: Marc Ponnet (managing director) and Lieveke Reynaert (managing director) · General meeting of 30-06-2022 · Gazette deed
Capital decrease of €9,800,000 to €200,000
Capital from €10,000,000 to €200,000 · Appointments: Laboflora NV, Lieveke Reynaert (managing director), CICERONE NV, BELSAC BVBA and Marc Ponnet (managing director) · Permanent representatives: Marc Ponnet and Lieveke Reynaert · General meeting of 02-05-2017 · Gazette deed
Official details
Source: KBO- Status
- Active since 20-10-1992Normal situation
- Activity
- “Het aanmaken,het factureren,kopen en verkopen,verhandelen,afvullen,verpakken,verdelen,in- en uitvoer van alle cosmetica produkten,in de ruimste zin…” (deed in Dutch)From the articles, 8 activitiesNo NACE code in the KBO yet
- Financial year end
- 31 December
- Peppol
- Reachable since 17-10-2025
Insights on LABOFLORA EN/OF MARC PONNET EN/OF LIEVEKE REYNAERT
LABOFLORA EN/OF MARC PONNET EN/OF LIEVEKE REYNAERT has existed since 1992. In 2010 the gross margin rose from €45,153 to €446,038.
Monbeau holds 90% of the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about LABOFLORA EN/OF MARC PONNET EN/OF LIEVEKE REYNAERT
- What is the company number of LABOFLORA EN/OF MARC PONNET EN/OF LIEVEKE REYNAERT?
- The company number of LABOFLORA EN/OF MARC PONNET EN/OF LIEVEKE REYNAERT is 0448.541.064. The VAT number is the same number with BE in front: BE 0448.541.064.
- Where is LABOFLORA EN/OF MARC PONNET EN/OF LIEVEKE REYNAERT based?
- The registered office is at Herpelstraat 4, 9688 Maarkedal.Company details
- What is the legal form of LABOFLORA EN/OF MARC PONNET EN/OF LIEVEKE REYNAERT?
- LABOFLORA EN/OF MARC PONNET EN/OF LIEVEKE REYNAERT is a public limited company (NV).
- When was LABOFLORA EN/OF MARC PONNET EN/OF LIEVEKE REYNAERT founded?
- LABOFLORA EN/OF MARC PONNET EN/OF LIEVEKE REYNAERT was founded on 20-10-1992.
- Is LABOFLORA EN/OF MARC PONNET EN/OF LIEVEKE REYNAERT still active?
- Yes, LABOFLORA EN/OF MARC PONNET EN/OF LIEVEKE REYNAERT is an active enterprise in the KBO register.
- What is the turnover of LABOFLORA EN/OF MARC PONNET EN/OF LIEVEKE REYNAERT?
- The turnover in financial year 2025 is ≈ €590,000. This figure is estimated from the gross margin of €251,246 and 2,274 comparable companies of the same size. It probably lies between €360,000 and €1.0m. It is a rough estimate.Financials
- Is LABOFLORA EN/OF MARC PONNET EN/OF LIEVEKE REYNAERT profitable?
- In financial year 2025, LABOFLORA EN/OF MARC PONNET EN/OF LIEVEKE REYNAERT made a profit of €85,492.
- Where can I find the annual accounts of LABOFLORA EN/OF MARC PONNET EN/OF LIEVEKE REYNAERT?
- LABOFLORA EN/OF MARC PONNET EN/OF LIEVEKE REYNAERT filed 33 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of LABOFLORA EN/OF MARC PONNET EN/OF LIEVEKE REYNAERT due?
- LABOFLORA EN/OF MARC PONNET EN/OF LIEVEKE REYNAERT must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.